Health potential of soy isoflavones for menopausal women

Public Health Nutrition

Volumn 2, Issue 4, 1999, Pages 489-504

  Anderson, John J B ^a   Anthony, Mary S ^b   Cline, J Mark ^b   Washburn, Scott A ^b   Garner, Sanford C ^c  

^a IL   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood lipids; Cancer; Cardiovascular diseases; Climocteric symptoms; Genistein; Isoflavones; Menopause; Osteoporosis; Phyto oestrogens; SERMs

Indexed keywords

DAIDZEIN; GENISTEIN; GLYCITEIN; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOYBEAN PROTEIN;

BONE DENSITY; BREAST CANCER; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CHEMICAL STRUCTURE; CLIMACTERIUM; COLON CANCER; DOSE RESPONSE; HUMAN; LIPID BLOOD LEVEL; MENOPAUSE; NONHUMAN; OSTEOPOROSIS; PHYTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; SOYBEAN; UTERUS CANCER;

ANIMALIA; GLYCINE MAX; PRIMATES; RODENTIA;

EID: 0033430371     PISSN: 13689800     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1368980099000671     Document Type: Review

References (107)

1. Adlercreutz HL, ed. Balliere's Clinical Endocrinology and Metabolism, Vol. 12. London: Ballière Tyndall, 1998.
2. Adlercreutz HL, Mazur W. Phyto-oestrogens and western diseases. Ann. Med. 1997; 29: 95-120.
3. Adlercruetz H, Markkanen H, Watanabe S. Plasma concentrations of phytoestrogens in Japanese men. Lancet 1993; 342: 1209-10.
4. Wang H-J, Murphy PA. Isoflavone content in commercial soybean foods. J. Agric. Food Chem. 1994; 42: 1666-73.
5. Franke AA, Custer LJ, Cerna CM, Narala KK. Quantitation of phytoestrogens in legumes by HPLC. J. Agric. Food Chem. 1994; 42: 1905-13.
6. Kurzer MS, Xu X. Dietary phytoestrogens. Annu. Rev. Nutr. 1997; 17: 353-81.
7. Fukutake M, Takahashi M, Ishida K, Kawamura H, Sugimura T, Wakabayashi K. Quantification of genistein and genistin in soybeans and soybean products. Food Chem. Toxicol. 1996; 34: 457-61.
8. Kaufman PB, Duke JA, Brielmann H, Boik J, Hoyt JE. A comparative study of leguminous plants as sources of isoflavones, genistein and daidzein: implications for human nutrition and health. J Alternat. Complementary Med. 1997; 3: 7-12.
9. Miksicek RJ. Commonly occurring plant flavonoids have estrogenic activity. Mol. Pharmacol. 1993; 44: 37-43.
10. Kuiper GGJM, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998; 139; 4252-63.
11. Miksicek RJ. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. SteroidBiochem. Mol. Biol. 1994; 49; 153-60.
12. Adlercreutz H, Fotsis T, Bannwart C, et al. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J. Steroid Biochem. 1986; 25: 791-7.
13. King RA, Bursill DB. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am. J. Clin. Nutr. 1998; 67: 867-72.
14. Sfakianos J, Coward L, Kirk M, Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J. Nutr. 1997; 127: 1260-8.
15. Bennetts HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust. Vet. J. 1946; 22: 2-12.
16. 3: potential relation to a plasmalemmal receptor to the acute enhancement of intestinal calcium transport in chicks. J. Nutr. 1995; 125: S1695-8.
17. Machelon V, Nome F, Grosse B, Lieberherr M. Progesterone triggers rapid transmembrane calcium influx and/or calcium mobilization from endoplasmic reticulum, via a pertussisinsensitive G-protein in granulosa cells in relation to luteinization process. J. Cell. Biochem. 1996; 61: 619-28.
18. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu. Rev. Public Health 1998; 19: 55-72.
19. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy estimates from a nationally representative cohort study. Am. J. Epidemiol. 1997; 145: 536-45.
20. Hulley S, Grady D, Bush T, et al. for the Heart and Estrogen/ progestin Replacement Study (HERS) Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-13.
21. Anderson JW, Johnstone BM, Cook-Newell ME. Metaanalysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 1995; 333: 276-82.
22. Crouse JR, Morgan TM, Terry JG, Ellis J, Vitolins M., Burke GL. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch. Intern. Med., in press.
23. Baum JA, Teng H, Erdman JW, et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am. J. Clin. Nutr. 1998; 68: 545-51.
24. Anthony MS, Clarkson TB, Bullock BC, Wagner JD. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2524-31.
25. Anthony MS, Clarkson TB, Williams JK. Effect of soy isoflavones on atherosclerosis potential mechanisms. Am. J. Clin. Nutr. 1998; 68 (Suppl. 6): S1390-3.
26. Clarkson TB, Anthony MS, Williams JK, Honore EK, Cline JM. The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy. Proc. Soc. Exp. Biol. Med. 1998; 217: 365-8.
27. Anthony MS, Clarkson TB. Comparison of soy phytoestrogens and conjugated equine estrogens on atherosclerosis progression in postmenopausal monkeys. Circulation 1998; 97: 829 (abstract).
28. Clarkson TB, Anthony MS. Effect of hormone replacement therapy on internal carotid artery atherosclerosis of postmenopausal monkeys. Circulation 1998; 97: 830 (abstract).
29. Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 3392-8.
30. Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Croft KD. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J. Nutr. 1998; 128: 728-32.
31. Greaves KA, Parks JS, Williams JK, Wagner JD. Intact dietary soy protein, but not an isoflavone-rich soy extract added to casein protein improves plasma lipids in ovariectomized cynomolgus monkeys. J. Nutr., in press.
32. Honoré EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance vascular reactivity in atherosclerotic female macaques. Fertil. Steril. 1997; 67: 148-54.
33. Hodgson JM, Croft KD, Puddey IB, Mori TA, Beillin LJ. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum. J. Nutr. Biochem. 1996; 7: 664-9.
34. Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, Rice-Evans CA. Antioxidant activity of phytoestrogenic isoflavones. Free Radic. Res. 1997; 26: 63-70.
35. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 1991; 88: 1785-92.
36. Fujio Y, Yamada F, Takahashi K, Shibata N. Responses of smooth muscle cells to platelet-derived growth factor are inhibited by herbimycin-A tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun. 1993; 195: 79-83.
37. Shimokado K, Yokota T, Umezawa K, Sasaguri T, Ogata J. Protein tyrosine kinase inhibitors inhibit chemotaxis of vascular smooth muscle cells. Arterioscler. Thromb. 1994; 14: 973-981.
38. Shimokado K, Umezawa K, Ogata J. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells. Exp. Cell. Res. 1995; 220: 266-73.
39. Kuruvilla A, Putcha G, Poulos E, Shearer WT. Tyrosine phosphorylation of phospholipase C concomitant with its activation by platelet-activating factor in a human B cell line. J. Immunol. 1993; 151: 637-48.
40. Murphy CT, Kellie S, Westwick J. Tyrosine-kinase activity in rabbit platelets stimulated with platelet-activating factor. The effect of inhibiting tyrosine kinase with genistein on platelet-signal-molecule elevation and functional responses. Eur. J. Biochem. 1993; 216: 639-51.
41. Asahi M, Yanagi S, Ohta S, et al. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein. FEBS Lett. 1992; 309: 10-14.
42. McNicol A. The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase. Prostaglandins Leukot. Essent. Fatty Acids 1993; 48: 379-84.
43. Helmeste DM, Tang SW. Tyrosine kinase inhibitors regulate serotonin uptake in platelets. Eur. J. Pharmacol. 1995; 280: R5-7.
44. Anderson JJB, Garner SC. Phytoestrogens and bone. In: Adlercreutz HL, ed. Balliere's Clinical Endocrinology and Metabolism, Vol. 12. London: Ballière Tyndall, 1998; 1-16.
45. Lees C, Ginn TA. Soy protein isolate diet does not prevent increased cortical bone turnover in ovariectomized macaques. Calcif. Tissue Int. 1998; 62: 557-8.
46. Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J. Nutr. 1996; 126: 161-7.
47. Anderson JJB, Ambrose WW, Garner SC. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc. Soc. Exp. Biol. Med. 1998; 217: 345-50.
48. Blair HC, Jordan SE, Peterson TG, Barnes S. Variable effects of tyrosine kinase inhibitors on avian oseoclastic activity and reduction of bone loss in ovariectomized rats. J. Cell. Biochem. 1996; 61: 629-37.
49. Potter SM, Baum JA, Teng H, Stillman RJ, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr. 1998; 68 (Suppl. 6): S1375-9.
50. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents. IARC Scientific Publication No. 120. Lyon: International Agency for Research on Cancer, 1992.
51. Wynder EL, Fujita Y, Harris RE, Hirayama T, Hiyama T. Comparative epidemiology of cancer between the United States and Japan: a second look. Cancer 1991; 67: 746-63.
52. Yu H, Harris RE, Gao YT, Gao R, Wynder EL. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int. J. Epidemiol. 1991; 20: 76-81.
53. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer Inst. 1993; 85: 1819-27.
54. Kato I, Tominaga S, Kuroishi T. Relationship between westernization of dietary habits and mortality from breast and ovarian cancers in Japan. Jpn. J. Cancer Res. 1987; 78: 349-57.
55. Hirose K, Tajima K, Hamajima N, et al. A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn. J. Cancer Res. 1995; 86: 146-54.
56. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997; 350: 990-4.
57. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast-cancer risk in Singapore. Lancet 1991; 337: 1197-200.
58. Witte JS, Ursin G, Siemiatycki J, Thompson WD, Paganini-Hill A, Haile RW. Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Res. Treat. 1997; 42: 243-51.
59. Wu AH, Ziegler RG, Horn-Ross PL, et al. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol. Biomark. Prevent. 1996; 5: 901-6.
60. Yuan JM, Wang QS, Ross RK, Henderson BE, Yu MC. Diet and breast cancer in Shanghai and Tianjin, China. Br. J. Cancer 1995; 71: 1353-8.
61. Zheng W, Dai Q, Custer LJ, Shu X, Wen W, Jin F, Franke AA. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol. Biomark. Prevent. 1999; 8: 35-40.
62. Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. Association of soy and fiber consumption with the risk of endometrial cancer. Am. J. Epidemiol. 1997; 146: 294-306.
63. Le Marchand L, Hankin JH, Wilkens LR, Kolonel LN, Englyst HN, Lyu LC. Dietary fiber and colorectal cancer risk. Epidemiology 1997; 8: 658-65.
64. Witte JS, Longnecker MP, Bird CL, Lee ER, Frankl HD, Haile RW. Relation of vegetable, fruit, and grain consumption to colorectal adenomatous polyps. Am. J. Epidemiol 1996; 144: 1015-25.
65. Lu LJ, Anderson KE, Grady JJ, Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol. Biomark. Prevent. 1996; 5: 63-70.
66. Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control 1997; 8: 146-58.
67. Barnes S. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res. Treat. 1997; 46: 169-79.
68. Lamartiniere CA, Moore J, Holland M, Barnes S. Neonatal genistein chemo prevents mammary cancer. Proc. Soc. Exp. Biol. Med. 1995; 208: 120-3.
69. Lamartiniere CA, Murrill WB, Manzolillo PA, et al. Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc. Soc. Exp. Biol. Med. 1998; 217: 358-64.
70. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998; 58: 3833-8.
71. Foth D, Cline JM. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am. J. Clin. Nutr. 1998; 68 (Suppl.): S1413-17.
72. Thiagarajan DG, Bennink MR, Bourquin LD, Kavas FA. Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. Am. J. Clin. Nutr. 1998; 68 (Suppl.): S1394-9.
73. Koratkar R, Rao AV. Effect of soya bean saponins on azoxymethane-induced preneoplastic lesions in the colon of mice. Nutr. Cancer 1997; 27: 206-9.
74. Rao CV, Wang CX, Simi B, et al. Enhancement of experimental colon cancer by genistein. Cancer Res. 1997; 57: 3717-22.
75. Sorensen IK, Kristiansen E, Mortensen A, et al. The effect of soy isoflavones on the development of intestinal neoplasia in ApcMin mouse. Cancer Lett 1998; 130: 217-25.
76. Weed HG, McGandy RB, Kennedy AR. Protection against dimethylhydrazine-induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor. Carcinogenesis 1985; 6: 1239-41.
77. Folman Y, Pope GS. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J. Endocrinol. 1966; 34: 215-25.
78. Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 1994; 21: 113-31.
79. Barnes S, Peterson TG. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc. Soc. Exp. Biol. Med. 1995; 208: 103-8.
80. Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem. Biophys. Res. Commun. 1991; 179: 661-7.
81. Akiyama T, Ishida JSN, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-speciflc protein kinases. J. Biol. Chem. 1987; 262: 5592-5.
82. Constantinou A, Huberman E. Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc. Soc. Exp. Biol. Med. 1995; 208: 109-15.
83. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med. 1995; 208: 124-30.
84. Kiguchi K, Glesne D, Chubb CH, Fujiki H, Huberman E. Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A. Cell Growth Differ. 1994; 5: 995-1004.
85. Fotsis T, Pepper M, Adlercreutz H, et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA 1993; 90: 2690-4.
86. Sathyamoorthy N, Gilsdorf JS, Wang TT. Differential effect of genistein on transforming growth factor beta 1 expression in normal and malignant mammary epithelial cells. Anticancer Res. 1998; 18: 2449-53.
87. Rao AV, Sung MK. Saponins as anticarcinogens. J. Nutr. 1995; 125 (Suppl. 3): S717-24.
88. Shamsuddin AM. Inositol phosphates have novel anticancer function. J. Nutr. 1995; 125 (Suppl. 3): S725-32.
89. Kennedy AR. The evidence for soybean products as cancer preventive agents. J. Nutr. 1995; 125 (Suppl. 3); S733-43.
90. Miksicek RJ, Lei Y, Wang Y. Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells. Breast Cancer Res. Treat. 1993; 26: 163-74.
91. Zhang QX, Hilsenbeck SG, Fuqua SA, Borg A. Multiple splicing variants of the estrogen receptor are present in individual human breast tumors. J. Steroid Biochem. Mol. Biol. 1996; 59: 251-60.
92. Makela S, Davis VL, Tally WC, et al. Dietary estrogens act through estrogen receptor mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ. Health Perspect. 1994; 102: 572-8.
93. McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am. J. Clin. Nutr. 1998; 68 (Suppl.): S1431-5.
94. Clarke RB, Howell A, Potten CS, Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 1997; 57: 4987-91.
95. Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. The variable metabolic response to dietary isoflavones in humans. Proc. Soc. Exp. Biol. Med. 1995; 208: 40-3.
96. Boulet MJ, Odden BJ, Lehert P, Vemer HM, Visser A. Climacteric and menopause in seven southeast Asian countries. Maturitas 1994; 19: 157-76.
97. Notelovitz M. Estrogen replacement therapy indications, contraindications, and agent selection. Am. J. Obstet. Gynecol. 1989; 161: 8-17.
98. Adlercreutz H. Western diets and western diseases: some hormonal and biochemical mechanisms and associations. Scand. J. Clin. Lab. Invest. 1990; 50 (Suppl.): 3-23.
99. Hughes CL. Effects of phytoestrogens on GnRH-induced luteinizing hormone secretion in ovariectomized rats. Reprod. Toxicol. 1988; 1: 179-81.
100. Hughes CL, Kaldas RS, Weisinger AS, McCants CE, Basham KB. Acute and subacute effects of naturally occurring estrogens on luteinizing hormone secretion in the ovariectomized rat: 1. Reprod. Toxicol. 1991; 5: 127-32.
101. Hughes CL, Chakinali MM, Reece SG, Miller RN, Schomberg DW, Basham KB. Acute and subacute effects of naturally occurring estrogens on luteinizing hormone secretion in the ovariectomized rat: 2. Reprod. Toxicol. 1991; 5: 133-7.
102. Cassidy A, Bingham S, Setchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr. 1994; 60: 333-40.
103. Murkies AL, Lombard C, Strauss BJG, Wikcox G, Burger HG, Morton MS. Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas 1995; 21: 189-95.
104. Brzezinski A, Adlercreutz H, Shaoul R, Shmueli A, Reosler A, Schenker JG. Phytoestrogen-rich diet for postmenopausal women. Fifth World Congress on Gynecology, Endocrinology, Barcelona, Spain, 1996. Abstract FC.H-02.
105. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet. Gynecol. 1998; 91: 6-11.
106. Washburn SA, Burke GL, Morgan TG, Anthony MS. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999; 6: 7-13.
107. Anthony MS, Clarkson TB, Hughes CL. Plant and mammalian estrogen effects on plasma lipids of female monkeys. Circulation 1994; 90: 1-235 (abstract).